138 related articles for article (PubMed ID: 15730056)
21. Bone matrix mineralization and osteocyte lacunae characteristics in patients with chronic kidney disease - mineral bone disorder (CKD-MBD).
Misof BM; Blouin S; Roschger P; Werzowa J; Klaushofer K; Lehmann G
J Musculoskelet Neuronal Interact; 2019 Jun; 19(2):196-206. PubMed ID: 31186390
[TBL] [Abstract][Full Text] [Related]
22. Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure?
Behets GJ; Dams G; Vercauteren SR; Damment SJ; Bouillon R; De Broe ME; D'Haese PC
J Am Soc Nephrol; 2004 Aug; 15(8):2219-28. PubMed ID: 15284308
[TBL] [Abstract][Full Text] [Related]
23. FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis.
Lima F; El-Husseini A; Monier-Faugere MC; David V; Mawad H; Quarles D; Malluche HH
Clin Nephrol; 2014 Nov; 82(5):287-95. PubMed ID: 25208316
[TBL] [Abstract][Full Text] [Related]
24. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol.
Bordier PJ; Marie PJ; Arnaud CD
Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669
[No Abstract] [Full Text] [Related]
25. Repression of osteocyte Wnt/β-catenin signaling is an early event in the progression of renal osteodystrophy.
Sabbagh Y; Graciolli FG; O'Brien S; Tang W; dos Reis LM; Ryan S; Phillips L; Boulanger J; Song W; Bracken C; Liu S; Ledbetter S; Dechow P; Canziani ME; Carvalho AB; Jorgetti V; Moyses RM; Schiavi SC
J Bone Miner Res; 2012 Aug; 27(8):1757-72. PubMed ID: 22492547
[TBL] [Abstract][Full Text] [Related]
26. Bone turnover, osteopenia and vascular calcifications in hemodialysis patients. A histomorphometric and multislice CT study.
Coen G; Ballanti P; Mantella D; Manni M; Lippi B; Pierantozzi A; Di Giulio S; Pellegrino L; Romagnoli A; Simonetti G; Splendiani G
Am J Nephrol; 2009; 29(3):145-52. PubMed ID: 18753739
[TBL] [Abstract][Full Text] [Related]
27. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients.
Lehmann G; Ott U; Stein G; Steiner T; Wolf G
Transplant Proc; 2007 Dec; 39(10):3153-8. PubMed ID: 18089342
[TBL] [Abstract][Full Text] [Related]
28. Histomorphometric measurements of bone turnover, mineralization, and volume.
Ott SM
Clin J Am Soc Nephrol; 2008 Nov; 3 Suppl 3(Suppl 3):S151-6. PubMed ID: 18988700
[TBL] [Abstract][Full Text] [Related]
29. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
[TBL] [Abstract][Full Text] [Related]
30. The unexpected presence of iron in bone biopsies of hemodialysis patients.
Custodio MR; Elias RM; Velasquez WD; Dos Reis LM; Oliveira IB; Moysés RMA; Carvalho AB; Jorgetti V
Int Urol Nephrol; 2018 Oct; 50(10):1907-1912. PubMed ID: 30136087
[TBL] [Abstract][Full Text] [Related]
31. Comparison between the lengths of individual osteoid seams and resorption cavities in human iliac crest cancellous bone.
Yamaguchi K; Croucher PI; Compston JE
Bone Miner; 1993 Oct; 23(1):27-33. PubMed ID: 8274877
[TBL] [Abstract][Full Text] [Related]
32. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7.
González EA; Lund RJ; Martin KJ; McCartney JE; Tondravi MM; Sampath TK; Hruska KA
Kidney Int; 2002 Apr; 61(4):1322-31. PubMed ID: 11918739
[TBL] [Abstract][Full Text] [Related]
33. Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate.
Behets GJ; Verberckmoes SC; Oste L; Bervoets AR; Salomé M; Cox AG; Denton J; De Broe ME; D'Haese PC
Kidney Int; 2005 May; 67(5):1830-6. PubMed ID: 15840030
[TBL] [Abstract][Full Text] [Related]
34. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling.
Rojas E; Carlini RG; Clesca P; Arminio A; Suniaga O; De Elguezabal K; Weisinger JR; Hruska KA; Bellorin-Font E
Kidney Int; 2003 May; 63(5):1915-23. PubMed ID: 12675872
[TBL] [Abstract][Full Text] [Related]
35. Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure.
Damment S; Secker R; Shen V; Lorenzo V; Rodriguez M
Nephrol Dial Transplant; 2011 Jun; 26(6):1803-12. PubMed ID: 21098011
[TBL] [Abstract][Full Text] [Related]
36. [Study of renal osteodystrophy by bone biopsy. Age as an independent factor. Diagnostic value of bone remodeling markers].
Jarava C; Armas JR; Palma A
Nefrologia; 2000; 20(4):362-72. PubMed ID: 11039262
[TBL] [Abstract][Full Text] [Related]
37. Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients.
Malluche HH; Mawad HW; Monier-Faugere MC
J Bone Miner Res; 2011 Jun; 26(6):1368-76. PubMed ID: 21611975
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry.
Ferreira A; Saraiva M; Behets G; Macedo A; Galvão M; D'Haese P; Drüeke TB
J Nephrol; 2009; 22(6):783-93. PubMed ID: 19967658
[TBL] [Abstract][Full Text] [Related]
39. Bone histomorphometry and indicators of bone and mineral metabolism in wait-listed dialysis patients.
Keronen S; Martola L; Finne P; Burton IS; Kauppila L; Kröger H; Larsson TE; Honkanen E
Clin Nephrol; 2016 Mar; 85(3):127-34. PubMed ID: 26833298
[TBL] [Abstract][Full Text] [Related]
40. Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease.
Yajima A; Inaba M; Tominaga Y; Tanaka M; Otsubo S; Nitta K; Ito A; Satoh S
Ther Apher Dial; 2013 Apr; 17 Suppl 1():41-8. PubMed ID: 23586512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
